Significant change in ZAP-70 expression during the course of chronic lymphocytic leukemia

European Journal of Haematology

Volumn 84, Issue 6, 2010, Pages 513-517

  Vroblova, Vladimira ^a   Vrbacky, Filip ^a   Hrudkova, Monika ^a   Jankovicova, Karolína ^a   Schmitzova, Daniela ^a   Maly, Jaroslav ^a   Krejsek, Jan ^a   Smolej, Lukas ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Chronic lymphocytic leukemia; Clinical course; IgVH mutational status; ZAP 70 expression

Indexed keywords

PREDNISONE; PROTEIN KINASE ZAP 70;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RELAPSE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HEMOLYTIC ANEMIA; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MUTATION; PILOT PROJECTS; RECURRENCE; TUMOR MARKERS, BIOLOGICAL; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 77952586458     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01425.x     Document Type: Article

References (21)

1. Chiorazzi N, Allen SL, Ferrarini M. Clinical and laboratory parameters that define clinically relevant B-CLL subgroups. Curr Top Microbiol Immunol 2005 294: 109 133.
2. Weiss A, Iwashima M, Irving B, van Oers NS, Kadlecek TA, Straus D, Chan A. Molecular and genetic insights into T cell antigen receptor signal transduction. Adv Exp Med Biol 1994 365: 53 62.
3. Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001 194: 1639 1647.
4. Schroers R, Griesinger F, Trumper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Duhrsen U, Durig J. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 2005 19: 750 758.
5. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marce S, Lopez-Guillermo A, Campo E, Montserrat E. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003 348: 1764 1775. (Pubitemid 36514707) (Pubitemid 36514707)
6. Durig J, Naschar M, Schmucker U, Renzing-Kohler K, Holter T, Huttmann A, Duhrsen U. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Leukemia 2002 16: 30 5.
7. Thornton PD, Fernandez C, Giustolisi GM, Morilla R, Atkinson S, A'Hern RP, Matutes E, Catovsky D. CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia. Hematol J 2004 5: 145 151.
8. Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO, Jilani I, Lerner S, Kantarjian HM, Albitar M. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001 98: 181 186.
9. Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK, Oscier DG. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002 99: 1023 1029.
10. Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004 363: 105 111.
11. Rassenti LZ, Huynh L, Toy TL, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004 351: 893 901.
12. Del Principe MI, Del Poeta G, Buccisano F, et al. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood 2006 108: 853 861.
13. Villamor N, Crespo M, Bosch F, Muntanola A, Gune E, Aymerich M, López-Guillermo A, Campo E, Montserrat E. ZAP-70 expression remains stable during the course of chronic lymphocytic leukemia. Leuk Lymphoma 2005 46 (Suppl. 1 S43.
14. Durig J, Nuckel H, Cremer M, Fuhrer A, Halfmeyer K, Fandrey J, Moroy T, Klein-Hitpass L, Duhrsen U. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia 2003 17: 2426 2434.
15. Poulain S, Benard C, Daudignon A, Le BF, Morel P, Duthilleul P. Is ZAP-70 expression stable over time in B chronic lymphocytic leukaemia? Leuk Lymphoma 2007 48: 1219 1221.
16. Gibbs G, Bromidge T, Howe D, Johnson S. ZAP-70 expression remains stable in chronic lymphocytic leukaemia. Int J Lab Hematol 2007 29: 225 227.
17. Boelens J, Lust S, Van Bockstaele F, Van Gele M, Janssens A, Derycke L, Vanhoecke B, Philippé J, Bracke M, Offner F. Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia. Leuk Res 2009 33: 1335 1343.
18. Bojarska-Junak A, Giannopoulos K, Kowal M, Dmoszyńska A, Roliński J. Comparison of methods for determining zeta-chain associated protein-70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL). Cytometry B Clin Cytom 2006 70: 293 301.
19. European Research Initiative on Chronic Lymphocytic Leukemia (ERIC): standardization & harmonization of cytometric analysis of ZAP70. http://www.ericll.org/downloads/ZAP-70-Staining.pdf. Accessed January 16, 2010.
20. Letestu R, Rawstron A, Ghia P, et al. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: a multicentric international harmonization process. Cytometry B Clin Cytom 2006 70: 309 314.
21. Le Garff-Tavernier M, Ticchioni M, Brissard M, Salmon C, Raynaud S, Davi F, Bernard A, Merle-Béral H, Ajchenbaum-Cymbalista F, Letestu R. National standardization of ZAP-70 determination by flow cytometry: the French experience. Cytometry B Clin Cytom 2007 72: 103 108.